OMERS ADMINISTRATION Corp Invests $5.25 Million in CME Group Inc. $CME

OMERS ADMINISTRATION Corp acquired a new position in CME Group Inc. (NASDAQ:CME) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 23,789 shares of the financial services provider’s stock, valued at approximately $5,253,000.

Several other large investors also recently added to or reduced their stakes in the business. Empowered Funds LLC increased its stake in shares of CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares in the last quarter. Marshall Wace LLP lifted its position in CME Group by 103.1% during the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after purchasing an additional 121,707 shares in the last quarter. Federated Hermes Inc. grew its holdings in CME Group by 1,325.2% during the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after purchasing an additional 21,918 shares during the period. Nebula Research & Development LLC purchased a new stake in CME Group in the second quarter worth about $992,000. Finally, The Manufacturers Life Insurance Company increased its position in CME Group by 2.6% in the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after buying an additional 7,397 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard bought 325 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the topic of a number of analyst reports. UBS Group lowered their price objective on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research report on Monday, July 6th. The Goldman Sachs Group reduced their target price on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday, June 30th. Deutsche Bank Aktiengesellschaft cut shares of CME Group from a “buy” rating to a “hold” rating and decreased their target price for the stock from $286.00 to $270.00 in a research note on Wednesday, August 19th. Bank of America lifted their price target on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday, July 23rd. Finally, TD Cowen dropped their price target on shares of CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $288.56.

CME Group Price Performance

CME stock opened at $279.17 on Tuesday. The company has a market capitalization of $100.38 billion, a PE ratio of 23.68, a price-to-earnings-growth ratio of 3.27 and a beta of 0.23. The company’s fifty day moving average price is $251.43 and its 200-day moving average price is $279.47. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the business earned $2.96 earnings per share. The firm’s revenue for the quarter was up .8% on a year-over-year basis. On average, equities analysts anticipate that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio is currently 44.11%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.